<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.114264</article-id><article-id pub-id-type="publisher-id">ACM-41867</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210400000_75497989.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  IgG4相关腹膜后纤维化致急性肾损伤和硬化性胆管炎1例及文献复习
  Acute Kidney Injury and Sclerosing Cholangitis due to IgG4-Related Retroperitoneal Fibrosis: A Case Report and Literature Review
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>石</surname><given-names>晓梦</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>郎</surname><given-names>艳华</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>肖</surname><given-names>淑佼</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邵</surname><given-names>乐平</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青岛大学附属医院护理部，山东 青岛</addr-line></aff><aff id="aff2"><addr-line>青岛大学附属市立医院肾内科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>04</month><year>2021</year></pub-date><volume>11</volume><issue>04</issue><fpage>1208</fpage><lpage>1213</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：通过1随访长达8年的IgG4相关疾病(IgG4-related disease, IgG4-RD)患者诊治过程探讨该病的临床特征和诊治进展。方法：对1例IgG4-RD患者的诊治过程进行描述和分析，结合文献和最新进展进行文献复习。结果：老年男性患者，于2011年6月因“左下肢水肿4月余，双下肢水肿并加重10天”第1次入院，CT显示后腹膜增厚和双侧肾盂积水，诊断为特发性腹膜后纤维化、急性梗阻性肾病和急性肾衰，给予皮质激素治疗后迅速好转。2013年5月因“腹痛1月，全身皮肤及巩膜黄染5天”第2次入院，影像学检查发现近端肝内狭窄伴远端胆管扩张，肝门软组织占位，诊断为胆管癌。但在长期随访中发现血清IgG4水平异常升高，病程良好，而且激素治疗有效，最终诊断为IgG4相关硬化性胆管炎。结论：IgG4-RD可在不同时间先后以IgG4相关腹膜后纤维化和IgG4相关硬化性胆管炎形式发病，前者可表现独特的影像学特点，后者可高度模拟胆管癌的影像学改变，容易误诊。
    Objective: We discuss the clinical characteristics and progress in diagnosis and treatment of IgG4-related disease (IgG4-RD) by following up a patient with this disease for up to 8 years. Methods: The diagnosis and treatment of a case with IgG4-RD were described and analyzed. Meanwhile, a literature review was carried out by focusing on IgG4 related retroperitoneal fibrosis (IgG4-RPF) and IgG4-related sclerosing cholangitis (IgG4-SC). Methods: The elderly male patient was admitted to our hospital for the first time in June 2011 due to “left lower limb edema for more than 4 months, then progress to bilateral lower limb edema for 10 days”. CT revealed retroperitoneal membrane thickening and bilateral hydronephrosis. The patient was diagnosed as idiopathic retroperitoneal fibrosis, acute obstructive nephropathy, and acute renal failure. He improved rapidly by corticosteroid therapy. In May 2013, he was readmitted because of “abdominal pain for 1 month, yellow staining of skin and sclera for 5 days”. The imaging examination revealed proximal intrahepatic stenosis with distal bile duct dilation and soft tissue occupying lesions at hilar region, which might imply a diagnosis of cholangiocarcinoma. However, in the long-term follow-up, the course of the disease was good, and corticosteroid therapy was effective. Combining the evidence of abnormal increased serum IgG4 levels, the patient was finally diagnosed as IgG4-SC. Conclusions: IgG4-RD can occur at different times in the form of IgG4-RPF and IgG4-SC successively. The former may present unique imaging characteristics, while the latter may highly mimick cholangiocarcinoma and is easy to be misdiagnosed. 
  
 
</p></abstract><kwd-group><kwd>IgG4相关疾病，IgG4相关腹膜后纤维化，IgG4相关硬化性胆管炎，急性肾损伤，文献复习, IgG4-Related Disease</kwd><kwd> IgG4-Related Retroperitoneal Fibrosis</kwd><kwd> IgG4-Related Sclerosing Cholangitis</kwd><kwd> Acute Kidney Injury</kwd><kwd> Literature Review</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：通过1随访长达8年的IgG4相关疾病(IgG4-related disease, IgG4-RD)患者诊治过程探讨该病的临床特征和诊治进展。方法：对1例IgG4-RD患者的诊治过程进行描述和分析，结合文献和最新进展进行文献复习。结果：老年男性患者，于2011年6月因“左下肢水肿4月余，双下肢水肿并加重10天”第1次入院，CT显示后腹膜增厚和双侧肾盂积水，诊断为特发性腹膜后纤维化、急性梗阻性肾病和急性肾衰，给予皮质激素治疗后迅速好转。2013年5月因“腹痛1月，全身皮肤及巩膜黄染5天”第2次入院，影像学检查发现近端肝内狭窄伴远端胆管扩张，肝门软组织占位，诊断为胆管癌。但在长期随访中发现血清IgG4水平异常升高，病程良好，而且激素治疗有效，最终诊断为IgG4相关硬化性胆管炎。结论：IgG4-RD可在不同时间先后以IgG4相关腹膜后纤维化和IgG4相关硬化性胆管炎形式发病，前者可表现独特的影像学特点，后者可高度模拟胆管癌的影像学改变，容易误诊。</p></sec><sec id="s2"><title>关键词</title><p>IgG4相关疾病，IgG4相关腹膜后纤维化，IgG4相关硬化性胆管炎，急性肾损伤，文献复习</p></sec><sec id="s3"><title>Acute Kidney Injury and Sclerosing Cholangitis due to IgG4-Related Retroperitoneal Fibrosis: A Case Report and Literature Review</title><p>Xiaomeng Shi<sup>1</sup>, Yanhua Lang<sup>2</sup>, Shujiao Xiao<sup>2</sup>, Leping Shao<sup>1*</sup></p><p><sup>1</sup>Department of Nephrology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Department of Nursing, Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/57-1572037x5_hanspub.png" /></p><p>Received: Mar. 19<sup>th</sup>, 2021; accepted: Apr. 19<sup>th</sup>, 2021; published: Apr. 26<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/57-1572037x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: We discuss the clinical characteristics and progress in diagnosis and treatment of IgG4-related disease (IgG4-RD) by following up a patient with this disease for up to 8 years. Methods: The diagnosis and treatment of a case with IgG4-RD were described and analyzed. Meanwhile, a literature review was carried out by focusing on IgG4 related retroperitoneal fibrosis (IgG4-RPF) and IgG4-related sclerosing cholangitis (IgG4-SC). Methods: The elderly male patient was admitted to our hospital for the first time in June 2011 due to “left lower limb edema for more than 4 months, then progress to bilateral lower limb edema for 10 days”. CT revealed retroperitoneal membrane thickening and bilateral hydronephrosis. The patient was diagnosed as idiopathic retroperitoneal fibrosis, acute obstructive nephropathy, and acute renal failure. He improved rapidly by corticosteroid therapy. In May 2013, he was readmitted because of “abdominal pain for 1 month, yellow staining of skin and sclera for 5 days”. The imaging examination revealed proximal intrahepatic stenosis with distal bile duct dilation and soft tissue occupying lesions at hilar region, which might imply a diagnosis of cholangiocarcinoma. However, in the long-term follow-up, the course of the disease was good, and corticosteroid therapy was effective. Combining the evidence of abnormal increased serum IgG4 levels, the patient was finally diagnosed as IgG4-SC. Conclusions: IgG4-RD can occur at different times in the form of IgG4-RPF and IgG4-SC successively. The former may present unique imaging characteristics, while the latter may highly mimick cholangiocarcinoma and is easy to be misdiagnosed.</p><p>Keywords:IgG4-Related Disease, IgG4-Related Retroperitoneal Fibrosis, IgG4-Related Sclerosing Cholangitis, Acute Kidney Injury, Literature Review</p><disp-formula id="hanspub.41867-formula39"><graphic xlink:href="//html.hanspub.org/file/57-1572037x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/57-1572037x8_hanspub.png" /> <img src="//html.hanspub.org/file/57-1572037x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>本文报道1随访长达8年的IgG4相关疾病(IgG4-related disease, IgG4-RD)的罕见病例，该患者为老年男性，临床表现为左下肢水肿4月余，双下肢水肿并加重10天，CT示后腹膜增厚和双侧肾盂积水，诊断为特发性腹膜后纤维化、急性梗阻性肾病和急性肾损伤，给予皮质激素治疗后迅速好转；2年后出现IgG4相关硬化性胆管炎，为罕见的IgG4-SC-2a型，易误诊为胆管癌。患者血清IgG4升高，病程良好，而且激素治疗有效。本文结合最新进展进行文献复习，探讨该病的临床特征和诊治策略。</p></sec><sec id="s6"><title>2. 病例</title><p>患者，男，52岁，因“左下肢水肿4月余，双下肢水肿并加重10天”于2011年6月第一次入院。患者伴弥漫性腹部隐痛，体重下降，未诉低热。半月前于当地医院查Scr 152 μmol/L (正常参考值57~111 μmol/L)，彩超示：双轻度积水。10天前感胸闷憋气，于当地查血沉增快，Scr 873 μmol/L，尿量约1200 ml/d (正常参考值1000~2000 ml/d)。CT示：后腹膜增厚，双肾肿胀，双输尿管上段及肾盂积水，见图1。患者既往史、用药史无特殊，吸烟史30余年(20支/天)，否认家族遗传病史。查体：BP 160/100 mmHg，双肺呼吸音粗，腹部无固定压痛和反跳痛，双下肢及阴囊水肿明显。实验室检查：Hb 93 g/L，嗜酸粒细胞计0.01 &#215; 10<sup>9</sup>/L；尿蛋白-；白蛋白31 g/L，CRP 19 mg/dL，(正常参考值Hb 130~175 g/L，嗜酸粒细胞计0.02 &#215; 10<sup>9</sup>~0.52 &#215; 10<sup>9</sup>/L；尿蛋白-；白蛋白40~55 g/L，CRP &lt; 10 mg/dL)。彩超：双肾皮质回声增强，双肾轻度积水，左肾12.1 cm &#215; 5.7 cm，右肾9.7 cm &#215; 4.8 cm，肝胆胰脾未见异常。初步诊断：特发性腹膜后纤维化，梗阻性肾病，急性肾损伤。给予甲强龙40 mg/d静滴。尿量明显增多，肾功能明显改善。1周后复查：Hb 104 g/L，Scr 134 μmol/L。出院后给予强的松30 mg/d联合环磷酰胺1.2 g/月，3个月后复查Scr 72 μmol/L。半年后失访。</p><p>图1. 肾脏CT平扫</p><p>2013年5月，患者因“腹痛1月，全身皮肤及巩膜黄染5天”第二次入院。1月前无明显诱因出现右上腹及脐周阵发性胀痛。10天前小便颜色加深，但尿量正常。5天前出现全身皮肤黄染，伴皮肤瘙痒、乏力。查体：全身皮肤及巩膜黄染，右上腹及脐周压痛，肝脏在剑突下2 cm可触及。实验室检查：ALT 280.00 U/L，AST 141.00 U/L，GGT 1064.00 U/L，ALP 1066.00 U/L，TBIL 192.50 μmol/L，DBIL135.20 μmol/L；IgA 4.49 g/L，IgM 5.60 g/L，IgG 11.60 g/L；Scr 36 μmol/L；Hb 97 g/L；CA 199 53.4 U/L；血、尿淀粉酶水平正常；(正常参考值ALT 5~40 U/L，AST 8~40 U/L，GGT 8~50 U/L，ALP 40~150 U/L，TBIL 2~19 μmol/L，DBIL 0.1~6.84 μmol/L；IgA 0.76~3.9 g/L，IgM 0.4~3.45 g/L，IgG 6~16 g/L；CA 199 0~40 KU/L)。增强CT示：肝门区软组织结节占位并肝内胆管扩张，肝胃间隙内多发结节，右肾体积较左肾小，见图2(①~③)。磁共振胰胆管造影(MRCP)：肝内胆管扩张，至肝门部截断，肝门处胆管管壁明显增厚，官腔狭窄、闭塞，胆总管未见明显扩张，胆囊未见明显显示，胰管未见明显扩张，见图2(④)。诊断：肝门胆管癌，胆汁淤积型肝炎。入院后给予保肝治疗和ERCP，术中胆管造影显示左肝内胆管至肝总管中段狭窄，左肝内胆管扩张，直径约0.8 cm (图3(①))。行肝总管活检并左肝内胆管7F &#215;15 cm塑料支架植入。肝总管活检病理检查因取材不理想，未获得足够诊断证据。肝总管液基涂片内未发现恶性肿瘤细胞。 患者好转出院，出院后1个月门诊随访时肝功完全正常。</p><p>2014年3月，患者因“反复全身皮肤及巩膜黄染加重”第三次入院，复查Hb 106 g/L，PLT 392 &#215; 10<sup>9</sup>/L，ESR 83 mm/h (正常参考值0~15 mm/h)，白蛋白30.0 g/L，TBIL 108.8 μmol/L，DBIL 78.9 μmol/L，IgA 2.30 g/L，IgM 0.91 g/L，IgG 19.70 g/L，CA 199 12.72 U/L，CRP 10.50 mg/L。ERCP显示胆管支架胆泥堵塞，左肝内胆管至肝总管狭窄，左肝内胆管扩张(图3(②))，给予更换8.5F &#215; 15cm支架。好转出院。</p><p>图2. 肾脏增强CT和磁共振胰胆管造影</p><p>图3. 胆管造影</p><p>2015年8月随访肝、肾功均正常，查体未见明显异常。查血IgG4 &gt; 3.52 g/L (正常参考值0~1.45 g/L)，结合患者良性的病程和多脏器受累的特点，考虑IgG4相关疾病，给予强的松40 mg/d，维持1月后逐月递减5 mg/d，最后维持5 mg/d至今。3个月时复查CA199 7.10 U/L，IgG4 1.56 g/L。增强CT显示肝门下方软组织结节较前缩小，ERCP显示肝内胆管狭窄和远端的扩张明显好转(图3(③))，遂行胆管支架取出术。患者随访至今，病情完全缓解未复发。</p><p>本研究经伦理委员会批准(2018临审字第028号)，并经患者知情同意。</p></sec><sec id="s7"><title>3. 讨论</title><p>IgG4相关疾病(IgG4-related disease, IgG4-RD)是一种日益共识的由免疫介导的慢性的复发–缓解型炎症伴纤维化疾病，其特点是血清IgG4增高，可全身多器官受累肿大，病理呈现致密性IgG4<sup>+</sup>淋巴浆细胞浸润、席纹状纤维化和闭塞性静脉炎等特征，通常对于类固醇治疗异常敏感 [<xref ref-type="bibr" rid="hanspub.41867-ref1">1</xref>]。与女性患者相比，男性患者以内脏器官受累多见 [<xref ref-type="bibr" rid="hanspub.41867-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.41867-ref2">2</xref>]。</p><p>特发性腹膜后纤维化(Idiopathic retroperitoneal fibrosis, IRF)是以包绕主动脉、髂动脉及其邻近组织的纤维–炎性组织增生为特点的罕见病，可使腹膜后空腔脏器受压而发生梗阻 [<xref ref-type="bibr" rid="hanspub.41867-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.41867-ref3">3</xref>]。患者首次入院时腹部CT特征并非典型的IRF表现(如主动脉周围软组织增生)，而是后腹膜增厚，但结合病人典型的症状(如弥漫性腹痛和体重下降)、体征(如髂静脉或淋巴管受压导致的单侧至双侧下肢浮肿)和实验室检查(如γ-球蛋白升高)，以及激素治疗后短期内尿量增加和肾功能迅速好转的特点，足以获得诊断。值得注意的是IRF导致的急性肾损伤往往恢复迅速，但影像学改变需要较长时间的治疗。</p><p>IgG4相关硬化性胆管炎(IgG4-related sclerosing cholangitis, IgG4-SC)是IgG4-RD累及胆管时的一种独特类型的胆管炎。据IgG4-SC的诊断标准 [<xref ref-type="bibr" rid="hanspub.41867-ref4">4</xref>]，该患者具备典型的肝内、外影像学特征和血清学证据，结合患者激素治疗有效和持久良好的病程，基本可确诊IgG4-SC。因此，IRF可修正为IgG4相关腹膜后纤维化(IgG4-RPF)，而IgG4-RPF又为IgG4-SC的确诊增加了说服力。该病例未获得足够的病理学证据，稍有遗憾。但因内镜下胆管活检的组织往往较少而难以获得包含胆管基质的标本，胆管活检诊断能力有限 [<xref ref-type="bibr" rid="hanspub.41867-ref5">5</xref>]。据IgG4-SC的分类方法 [<xref ref-type="bibr" rid="hanspub.41867-ref4">4</xref>]，结合影像学特征，该患者为最为罕见的2a型。另外，该患者未合并自身免疫性胰腺炎，属孤立性IgG4-SC。</p><p>该患者初始被误诊为胆管癌，但IgG4-SC误诊为胆管癌在文献中屡见不鲜 [<xref ref-type="bibr" rid="hanspub.41867-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.41867-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.41867-ref5">5</xref>]。血清IgG4水平升高、伴随疾病、胆管造影、胆道超声(对称性同心圆状胆道壁增厚和均质回声)、病理学证据、良好的病程以及激素治疗有效均可帮助确诊IgG4-SC。但血清IgG4的敏感性和特异性较差，但如果IgG4 &gt; 560 mg/dL可为IgG4-SC提供更可靠的诊断依据 [<xref ref-type="bibr" rid="hanspub.41867-ref4">4</xref>]。值得注意的是，正如本例患者所表现的，IgG4-RD各受累器官并非同时发病，而呈游走性特点。</p><p>另外，值得关注的是，血清IgG4的敏感性和特异性较差，3%~30%的IgG4-RD患者血清IgG4浓度正常，其他病患也可观察到血清IgG4浓度升高 [<xref ref-type="bibr" rid="hanspub.41867-ref1">1</xref>]。然而，血清IgG4水平与受累器官数目呈显著正相关。不同器官受累的患者血清IgG4浓度也存在差异，头颈部患病符合Mikulicz综合征并伴有腺体外全身受累的患者血清IgG4浓度最高，其中位数为1170 mg/dL (520~2178 mg/dL)；局限于头部和颈部的不完全Mikulicz综合征患者血清IgG4浓度的中位数为445 mg/dL (183~888 mg/dL)；肝、胆、胰受累的患者血清IgG4浓度的中位数为316 mg/dL (147~622 mg/dL)；RPF和/或主动脉炎患者的血清IgG4浓度最低，其中位数为178 mg/dL (63~322 mg/dL) [<xref ref-type="bibr" rid="hanspub.41867-ref4">4</xref>]。在随访中，还应注意的是，血清IgG4水平不能单独用于评估病情的活动或复发，而应结合影像学的改变和患者的症状和体征。</p><p>目前认为，在无禁忌情况下，糖皮质激素是治疗IgG4-RD的一线药物。起始诱导期建议强的松0.6 mg/kg/d (维持2~4周)，每1~2周减少5 mg/d，2~3月后逐渐减量至5 mg/d，维持至少3年。对于影像学和血清学指标恢复满意的患者，可停用激素，但要密切随访，注意复发。但梅奥医学中心推荐40 mg/d (维持4周)，随后每周减少5 mg/d，至11周停药。对于复发、激素依赖和激素抵抗的患者可加用免疫抑制剂，但免疫抑制剂的应用仍存争议 [<xref ref-type="bibr" rid="hanspub.41867-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.41867-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.41867-ref4">4</xref>]。</p><p>该IgG4-RPF患者未行血液净化治疗，单用激素治疗迅速缓解。对于诊断及时、诊断证据充分、无药物不可控制的急性心衰、高血压或高钾血症的患者，我们推荐单用激素治疗，以避免深静脉插管、双J管植入等导致感染等并发症。在IgG4-SC的诊治过程中，我们进行了ERCP并放置了胆管支架进行了胆道引流。最新IgG4-SC诊治指南也推荐胆管狭窄导致的黄疸进行胆管引流，但无胆管炎的轻度黄疸患者，在诊断明确时且无需病理检查时，优选激素治疗 [<xref ref-type="bibr" rid="hanspub.41867-ref4">4</xref>]。该患者硬化性胆管炎考虑为IgG4-RD复发时，立即用糖皮质激素治疗后效果明显，故未联合免疫抑制剂或使用单抗制剂。</p></sec><sec id="s8"><title>4. 结论</title><p>总之，本文我们描述了1例IgG4-RD老年男性患者，在不同时间先后以IgG4-RPF和IgG4-SC形式发病，后者极易误诊为胆管癌，但前者为后者的确诊提供了诊断证据和线索。同时，本文结合最新诊治指南对IgG4-RD的诊治进展进行了文献复习。</p></sec><sec id="s9"><title>利益冲突</title><p>所有作者均声明不存在利益冲突。</p></sec><sec id="s10"><title>基金项目</title><p>国家自然科学基金面上项目(81873594)。</p></sec><sec id="s11"><title>文章引用</title><p>石晓梦,郎艳华,肖淑佼,邵乐平. IgG4相关腹膜后纤维化致急性肾损伤和硬化性胆管炎1例及文献复习Acute Kidney Injury and Sclerosing Cholangitis due to IgG4-Related Retroperitoneal Fibrosis: A Case Report and Literature Review[J]. 临床医学进展, 2021, 11(04): 1208-1213. https://doi.org/10.12677/ACM.2021.114264</p></sec><sec id="s12"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.41867-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Khosroshahi, A., Wallace, Z.S., Crowe, J.L., et al. (2015) International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis &amp; Rheumatologyl, 67, 1688-1699.  
&lt;br&gt;https://doi.org/10.1002/art.39132</mixed-citation></ref><ref id="hanspub.41867-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, W., Xue, F., Wang, C., et al. (2018) Clinical Features and Prognostic Factors of Ten Patients with Renal Failure Caused by IgG4-Related Retroperitoneal Fibrosis. Oncotarget, 9, 2858-2865.  
&lt;br&gt;https://doi.org/10.18632/oncotarget.23103</mixed-citation></ref><ref id="hanspub.41867-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">张伟, 邵乐平, 马瑞霞, 等. 特发性腹膜后纤维化致肾衰竭二例[J]. 中华肾脏病杂志, 2011, 27(4): 308.  
http://www.chinadoi.cn/portal/mr.action?doi=10.3760/cma.j.issn.1001-7097.2011.04.019</mixed-citation></ref><ref id="hanspub.41867-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kamisawa, T., Nakazawa, T., Tazuma, S., et al. (2019) Clinical Practice Guidelines for IgG4-Related Sclerosing Cholangitis. Journal of Hepato-Biliary-Pancreatic Sciences, 26, 9-42. &lt;br&gt;https://doi.org/10.1002/jhbp.596</mixed-citation></ref><ref id="hanspub.41867-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kawakami, H., Zen, Y., Kuwatani, M., et al. (2010) Igg4-Related Sclerosing Cholangitis and Autoimmune Pancreatitis: Histological Assessment of Biopsies from Vater’s Ampulla and the Bile Duct. Journal of Gastroenterology and Hepatology, 25, 1648-1655. &lt;br&gt;https://doi.org/10.1111/j.1440-1746.2010.06346.x</mixed-citation></ref></ref-list></back></article>